- ►annals.org AM Kanaya, D Herrington, E Vittinghoff, F Lin, … - Annals of internal medicine, 2003 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Randomized trials of postmenopausal hormone therapy have found ... Cited by 193 - Related articles - BL Direct - All 7 versions
KL Margolis, DE Bonds, RJ Rodabough, L … - Diabetologia, 2004 - Springer Aims/hypothesis. Studies examining the effect of postmenopausal hormone therapy
on concentrations of glucose, insulin and diabetes incidence have been
inconclusive, in part because many of the studies were too small. We ... Cited by 125 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org [PDF] MA Espeland, PE Hogan, SE Fineberg, G … - Diabetes Care, 1998 - Am Diabetes Assoc F rom the Wake Forest University School of Medicine (MAE, PEH, GH),
Winston-Salem, North Caro lina ; the Indiana University School of Medicine
(SEF), Indianapolis, Indiana; the University of Iowa Lipid R esea rch ... Cited by 114 - Related articles - BL Direct - All 8 versions
- ►endojournals.org KE Friday, C Dong, RU Fontenot - Journal of Clinical Endocrinology & Metabolism, 2001 - Endocrine Soc When compared with 8 weeks of placebo, estrogen reduced fasting serum glucose
(7.2 ± 0.3 vs. 8.4 ± 0.4 mmol/L, P = 0.0003), glycated hemoglobin (8.7 ± 0.4%
vs. 9.3 ± 0.4%, P = 0.04), total cholesterol (5.27 ± 0.20 vs. 5.50 ± ... Cited by 60 - Related articles - BL Direct - All 6 versions
DE Bonds, N Lasser, L Qi, R Brzyski, B Caan, … - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 459–468 DOI 10.1007/s00125-005-0096-0 ARTICLE DE
Bonds . N. Lasser . L. Qi . R. Brzyski . B. Caan . G. Heiss . MC Limacher . ... Cited by 41 - Related articles - BL Direct - All 3 versions
JE Manson, EB Rimm, GA Colditz, WC Willett … - Annals of epidemiology, 1992 - ncbi.nlm.nih.gov The potential influence of postmenopausal estrogen therapy on the subsequent
development of non-insulin-dependent diabetes mellitus (NIDDM) is relatively
unexplored, despite postulated effects of these hormones on glucose ... Cited by 92 - Related articles - All 2 versions
- ►endojournals.org B Andersson, LA Mattsson, L Hahn, L Lapidus … - Journal of Clinical Endocrinology & Metabolism, 1997 - Endocrine Soc Hyperandrogenicity in women is closely associated with insulin resistance and a
risk factor for cardiovascular disease and noninsulin-dependent diabetes
mellitus (NIDDM). Therefore, 25 postmenopausal women with NIDDM and sex ... Cited by 156 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org Y Zhang, BV Howard, LD Cowan, J Yeh, CF … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—This report is based on 857 women who were both
nondiabetic and postmenopausal at the baseline examination (1989–1992) and who
completed a second examination (1993–1995) an average of 4 years later. ... Cited by 36 - Related articles - BL Direct - All 5 versions
PJ Manning, A Allum, S Jones, WHF … - Archives of Internal Medicine, 2001 - archinte.highwire.org Background Postmenopausal women with diabetes are at high risk for
cardiovascular disease, compared with their nondiabetic counterparts. Combined
continuous hormone replacement therapy (HRT) is associated with ... Cited by 46 - Related articles - BL Direct - All 5 versions
- ►ajph.org [PDF] LL Gabal, D Goodman-Gruen, E Barrett- … - American Journal of Public Health, 1997 - Am Public Health Assoc In every country and at every age, women are at lower risk for coronary heart
disease than men.1-5 This has led to the hypothesis that estrogen is cardiopro-
tective. Despite the increased use of postmenopausal estrogen replacement ... Cited by 44 - Related articles - BL Direct - All 5 versions
